These findings suggest that mutations driving abnormal tumor cell proliferation and immune evasion, such as CTNNB1 mutations leading to unchecked cell cycle progression and Wnt pathway activation, contribute to these outcomes. This evidence concerns the gene CTNNB1 and neoplasm.